DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma

Haematologica

Volumn 91, Issue 9, 2006, Pages 1252-1256

  Voso, Maria Teresa ^a   Gumiero, Daniela ^a   D'Alo', Francesco ^a   Guidi, Francesco ^a   Mansueto, Giovanna ^a   Di Febo, Anna Laura ^a   Massini, Giuseppina ^a   Martini, Maurizio ^a   Larocca, Luigi Maria ^a   Hohaus, Stefan ^a   Leone, Giuseppe ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

DAP kinase hypermethylation; Follicular lymphoma; Prognosis

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DEATH ASSOCIATED PROTEIN KINASE; DOXORUBICIN; FLUDARABINE; MESSENGER RNA; MITOXANTRONE; PREDNISONE; PROTEIN BCL 2; RITUXIMAB; VINCRISTINE;

ADULT; AGED; ARTICLE; BONE MARROW; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INFILTRATION; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; DEMOGRAPHY; DRUG DOSE REGIMEN; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PROGNOSIS;

ADULT; AGED; APOPTOSIS REGULATORY PROTEINS; BONE MARROW; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; DNA METHYLATION; FEMALE; HUMANS; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; PROGNOSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 33748761145     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Lai R, Arber DA, Chang KL, Wilson CS, Weiss LM. Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia. Mod Pathol 1998;11:864-9.
2. de Jong D. Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors. J Clin Oncol 2005;10:6358-63.
3. S. Cohen O, Kimchi A. DAP-kinase: from functional gene cloning to establishment of its role in apoptosis and cancer. Cell Death Differ 2001;8:6-15.
4. Ng MH. Death associated protein kinase: from regulation of apoptosis to tumor suppressive functions and B cell malignancies. Apoptosis 2002;7:261-70.
5. Rossi D, Capello D, Gloghini A, Franceschetti S, Paulli M, Bhatia K, et al. Aberrant promoter methylation of multiple genes throughout the clinicopathologic spectrum of B-cell neoplasia. Haematologica 2004;89:154-64.
6. Rambaldi A, Parlotti E, Oldani E, Della Starza I, Baccarani M, Cortelazzo S, et al. Quantitative PCR of bone marrow BCL2/IgH+ cells at diagnosis predicts treatment response and long-term outcome in follicular non-Hodgkin lymphoma. Blood 2005;105:3428-33.
7. Mandigers CM, Meijerink JP, Mensink EJ, Tonnissen EL, Hebeda KM, Bogman MJ, et al. Lack of correlation between numbers of circulating t(14:18)-positive cells and response to first-line treatment in follicular lymphoma. Blood 2001;98:940-4.
8. Gribben JG, Neuberg D, Freedman AS, Gimmi CD, Pesek KW, Barber M, et al. Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for cell lymphoma. Blood 1993;81:3449-57.
9. Ladetto M, Corradini P, Vallet S, Benedetti F, Vitolo U, Martelli M, et al. High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO). Blood 2002;100:1559-65.
10. Fernandez-Ruiz E, Cabrerizo M, Ortega M, Blas C, Llamas P, Santos-Roncero M, et al. High molecular response rate and clinical correlation in patients with follicular lymphoma treated with cyclophosphamide-vincristine-prednisone plus interferon α 2b. Clin Cancer Res 2003;9:2497-503.
11. Voso MT, Hohaus S, Moos M, Haas R. Lack of t(14;18) polymerase chain reaction-positive cells in highly purified CD34+ cells and their CD19 subsets in patients with follicular lymphoma. Blood 1997;89:3763-8.
12. Katzenellenbogen RA, Baylin SB, Herman JG. Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies. Blood 1999;93:4347-53.
13. Voso MT, Scardocci A, Guidi F, Zini G, Di Mario A, Pagano L, et al. Aberrant methylation of DAP-kinase in therapy-related acute myeloid leukemia and myelodysplastic syndromes. Blood 2004;103:698-700.
14. Solal-Celigny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R, et al. Follicular lymphoma international prognostic index. Blood 2004;104:1258-65.
15. Shiramizu B, Mick P. Epigenetic changes in the DAP-kinase CpG island in pediatric lymphoma. Med Pediatr Oncol 2003;41:527-31.
16. Tang X, Khuri FR, Lee JJ, Kemp BL, Liu D, Hong WK, et al. Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer. J Natl Cancer Inst 2000;92:1511-6.
17. Ottensmeier CH, Thompsett AR, Zhu D, Wilkins BS, Sweetenham JW, Stevenson FK. Analysis of VH genes in follicular and diffuse lymphoma shows ongoing somatic mutation and multiple isotype transcripts in early disease with changes during disease progression. Blood 1998;91:4292-9.
18. Reddy AN, Jiang WW, Kim M, Benoit N, Taylor R, Clinger J, et al. Death-associated protein kinase promoter hypermethylation in normal human lymphocytes. Cancer Res 2003;63:7694-8.
19. Ladetto M, Drandi D, Compagno M, Astolfi M, Volpato F, Voena C, et al. PCR-detectable nonneoplastic Bcl-2/IgH rearrangements are common in normal subjects and cancer patients at diagnosis but rare in subjects treated with chemotherapy. J Clin Oncol 2003;21:1398-403.
20. Apostolidis J, Gupta RK, Grenzelias D, Johnson PW, Pappa VI, Summers KE, et al. High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: ong-term clinical and molecular follow-up. J Clin Oncol 2000;18:527-36.